WO2004093804A3 - Human polypeptides encoded by polynucleotides and methods of their use - Google Patents

Human polypeptides encoded by polynucleotides and methods of their use Download PDF

Info

Publication number
WO2004093804A3
WO2004093804A3 PCT/US2004/012047 US2004012047W WO2004093804A3 WO 2004093804 A3 WO2004093804 A3 WO 2004093804A3 US 2004012047 W US2004012047 W US 2004012047W WO 2004093804 A3 WO2004093804 A3 WO 2004093804A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
polynucleotides
modulators
compositions
polypeptides encoded
Prior art date
Application number
PCT/US2004/012047
Other languages
French (fr)
Other versions
WO2004093804A2 (en
Inventor
Ernestine Lee
Kevin Hestir
Keting Chu
Lorianne Masuoka
Lewis Thomas Williams
Original Assignee
Five Prime Therapeutics Inc
Ernestine Lee
Kevin Hestir
Keting Chu
Lorianne Masuoka
Lewis Thomas Williams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc, Ernestine Lee, Kevin Hestir, Keting Chu, Lorianne Masuoka, Lewis Thomas Williams filed Critical Five Prime Therapeutics Inc
Publication of WO2004093804A2 publication Critical patent/WO2004093804A2/en
Publication of WO2004093804A3 publication Critical patent/WO2004093804A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides novel polynucleotides, related polypeptides, related nucleic acid and polypeptide compositions, and related modulators, such as antibodies and small molecule modulators. The invention also provides methods to make and use these polynucleotides, polypeptides, related compositions, and modulators. These methods include diagnostic, prophylactic and therapeutic applications. The compositions and methods of the invention are useful in diagnosis, prophylaxis, and treatment of proliferative, inflammatory, immune, infectious, metabolic, central nervous system, and bone and cartilage disorders.
PCT/US2004/012047 2003-04-18 2004-04-19 Human polypeptides encoded by polynucleotides and methods of their use WO2004093804A2 (en)

Applications Claiming Priority (26)

Application Number Priority Date Filing Date Title
US46373203P 2003-04-18 2003-04-18
US46370803P 2003-04-18 2003-04-18
US60/463,732 2003-04-18
US60/463,708 2003-04-18
US46719903P 2003-05-02 2003-05-02
US46723003P 2003-05-02 2003-05-02
US60/467,199 2003-05-02
US60/467,230 2003-05-02
US47133603P 2003-05-19 2003-05-19
US47130603P 2003-05-19 2003-05-19
US60/471,336 2003-05-19
US60/471,306 2003-05-19
US48522303P 2003-07-08 2003-07-08
US48522403P 2003-07-08 2003-07-08
US60/485,224 2003-07-08
US60/485,223 2003-07-08
US48644603P 2003-07-14 2003-07-14
US48648003P 2003-07-14 2003-07-14
US60/486,446 2003-07-14
US60/486,480 2003-07-14
US49357303P 2003-08-08 2003-08-08
US49357703P 2003-08-08 2003-08-08
US60/493,573 2003-08-08
US60/493,577 2003-08-08
US50505903P 2003-09-08 2003-09-08
US60/505,059 2003-09-24

Publications (2)

Publication Number Publication Date
WO2004093804A2 WO2004093804A2 (en) 2004-11-04
WO2004093804A3 true WO2004093804A3 (en) 2009-03-26

Family

ID=33314662

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/012047 WO2004093804A2 (en) 2003-04-18 2004-04-19 Human polypeptides encoded by polynucleotides and methods of their use

Country Status (1)

Country Link
WO (1) WO2004093804A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222070A1 (en) 2002-05-29 2005-10-06 Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung Pancreas-specific proteins
EP2161037A3 (en) 2003-04-22 2010-05-26 Ipsen Pharma Camptothecin-Somatostatin conjugates
PL1694354T3 (en) 2003-11-27 2009-12-31 Develogen Ag Method for preventing and treating diabetes using neurturin
GB0422901D0 (en) * 2004-10-14 2004-11-17 Ares Trading Sa Lipocalin protein
GB0423973D0 (en) * 2004-10-28 2004-12-01 Ares Trading Sa C1q related points
GB0423974D0 (en) * 2004-10-28 2004-12-01 Ares Trading Sa Proteins
EP1831370A4 (en) 2004-12-13 2009-08-12 Alethia Biotherapeutics Inc Polynucleotides and polypeptide sequences involved in the process of bone remodeling
EP2216339A1 (en) * 2006-01-16 2010-08-11 Compugen Ltd. Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
ITTO20060852A1 (en) * 2006-11-30 2008-06-01 Univ Degli Studi Torino METASTASE-SPECIFIC PEPTIDES AND THEIR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
WO2008079705A2 (en) * 2006-12-20 2008-07-03 Eli Lilly And Company Acyl-transferase
US20100204128A1 (en) * 2007-07-24 2010-08-12 Sanare Investment As Novel peptides
EP2190870A4 (en) * 2007-08-28 2010-12-01 Auckland Uniservices Ltd Cell marker of melanocyte cell lineage and uses thereof
WO2009083968A1 (en) * 2007-12-27 2009-07-09 Two To Biotech Ltd. Novel protein
JP2011509076A (en) 2007-12-28 2011-03-24 ノボ・ノルデイスク・エー／エス DDR1-mediated cell purification of the cells via precursors of pancreatic endocrine cells
CA2761614A1 (en) * 2009-05-08 2010-11-11 Functional Genetics, Inc. Human fg01 gene and its applications
WO2013155567A1 (en) * 2012-04-20 2013-10-24 Mat Malta Advanced Technologies Limited Sex determination genes
WO2016083466A1 (en) * 2014-11-26 2016-06-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel tumor suppressor gene and uses thereof for the treatment and diagnosis of cancer
WO2018208877A1 (en) * 2017-05-09 2018-11-15 Yale University Basehit, a high-throughput assay to identify proteins involved in host-microbe interaction
WO2023192883A2 (en) * 2022-03-31 2023-10-05 Emory University Rolling sensor systems for detecting analytes and diagnostic methods related thereto

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218117B1 (en) * 1998-06-15 2001-04-17 Mitokor Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218117B1 (en) * 1998-06-15 2001-04-17 Mitokor Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios

Also Published As

Publication number Publication date
WO2004093804A2 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
WO2004093804A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2004035732A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2004000997A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2008054561A3 (en) Proteins, nucleic acids encoding the same and associated methods of use
WO2004020595A8 (en) Novel human polypeptides encoded by polynucleotides
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2003080856A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004094651A3 (en) Novel human polypeptides encoded by polynucleotides
WO2002081518A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2005085280A3 (en) HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE
WO2004015060A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002081510A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2004020591A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2003029423A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004038003A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2003078572A3 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
WO2004094598A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2003022998A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002099116A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003040329A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002083841A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase